COLL vs COST · P/E 17, rev $181.9M vs P/E 55, rev $275.24B
Collegium Pharmaceutical Inc (COLL) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. Revenue was up 8.2% from 2024-09-01 to 2025-08-31. COST currently screens at market cap $430.32B and trailing P/E 54.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the COLL and COST stock pages for the full models.
Not investment advice.